Hospital
Healthalliance Hospital Marys Avenue Campus
Healthalliance Hospital Marys Avenue Campus was paid $12.84M by Medicaid between Sep 2019 and Dec 2024, across 168 billing codes. Its largest line is H0020, Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) — 12% of everything it billed.
33Billing provider infoHEALTHALLIANCE HOSPITAL MARYS AVENUE CAMPUS
KINGSTON, NY 12401
KINGSTON, NY 12401
33aNPI1932182599assigned 11/28/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.84M
24GClaims289,810
24DCodes billed168
24AFirst – last monthSep 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#73 of 231
Median peer was paid$561K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 767 | $77K | |
| 2020 | 2,133 | $243K | |
| 2021 | 32,004 | $1.38M | |
| 2022 | 64,358 | $3.18M | |
| 2023 | 97,936 | $4.14M | |
| 2024incomplete | 92,612 | $3.81M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 12% | 59,121 | 5,366 | $1.60M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 10,815 | 10,351 | $1.49M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.4% | 9,538 | 9,010 | $1.21M |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 7.8% | 5,722 | 764 | $995K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 6.0% | 12,359 | 1,693 | $766K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.6% | 5,482 | 5,191 | $717K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.9% | 3,296 | 2,818 | $631K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.0% | 1,919 | 1,865 | $510K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.2% | 1,536 | 1,518 | $412K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.1% | 3,064 | 2,985 | $398K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 3.0% | 4,095 | 3,129 | $385K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.9% | 3,275 | 2,612 | $376K |
156 more codes
| 80053 | Comprehensive metabolic panel | 2.6% | 14,977 | $338K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.3% | 8,044 | $300K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2.3% | 617 | $298K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.4% | 589 | $176K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.2% | 1,143 | $158K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 528 | $150K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 1,986 | $147K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 767 | $145K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.1% | 1,113 | $140K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 1,135 | $140K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,008 | $100K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 652 | $91K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,497 | $85K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 6,110 | $85K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,094 | $83K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 11,602 | $72K |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,395 | $68K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 330 | $53K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,600 | $46K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | <1% | 787 | $39K |
| S5161 | Emergency response system; service fee, per month (excludes installation and testing) | <1% | 1,452 | $38K |
| 83880 | <1% | 1,209 | $38K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 257 | $35K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 723 | $33K |
| 86850 | <1% | 1,000 | $32K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 270 | $32K |
| 29125 | <1% | 161 | $32K | |
| 12001 | <1% | 64 | $25K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 448 | $24K |
| 76801 | <1% | 272 | $24K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 164 | $23K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 322 | $22K |
| 70496 | <1% | 75 | $21K | |
| G0378 | Hospital observation service, per hour | <1% | 218 | $18K |
| 86900 | <1% | 1,035 | $17K | |
| 86901 | <1% | 1,031 | $16K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 90 | $16K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 429 | $15K |
| 90715 | <1% | 473 | $13K | |
| 76641 | <1% | 612 | $12K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 589 | $11K |
| 96367 | <1% | 470 | $10K | |
| 93970 | <1% | 28 | $9K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 273 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 427 | $8K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,036 | $6K |
| 81025 | <1% | 1,847 | $5K | |
| 93971 | <1% | 140 | $5K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,741 | $5K |
| 76830 | Ultrasound, transvaginal | <1% | 124 | $4K |
| 90837 | Psychotherapy session, about an hour | <1% | 29 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 281 | $3K |
| 0012A | <1% | 129 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,641 | $3K |
| 97161 | <1% | 34 | $3K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 14 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,612 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 711 | $3K |
| 93017 | <1% | 56 | $3K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 99 | $3K |
| 29130 | <1% | 12 | $2K | |
| 29530 | <1% | 12 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 668 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,443 | $2K |
| 76775 | <1% | 36 | $2K | |
| 92557 | <1% | 70 | $2K | |
| 0011A | <1% | 95 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 345 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,072 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,290 | $2K |
| 80061 | Lipid panel | <1% | 184 | $1K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 27 | $1K |
| 92567 | <1% | 92 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,305 | $1K |
| 85610 | <1% | 2,216 | $1K | |
| 85730 | <1% | 1,775 | $1K | |
| 82947 | <1% | 1,224 | $789.85 | |
| 70498 | <1% | 12 | $787.38 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,344 | $787.36 |
| 81001 | <1% | 3,928 | $761.40 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,174 | $751.59 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 245 | $701.75 |
| 0064A | <1% | 17 | $680.00 | |
| 76376 | <1% | 13 | $649.96 | |
| 77080 | <1% | 12 | $640.00 | |
| 85027 | <1% | 195 | $622.56 | |
| 83735 | <1% | 2,128 | $614.14 | |
| 94729 | <1% | 36 | $592.50 | |
| 84484 | <1% | 2,974 | $591.20 | |
| 82805 | <1% | 26 | $538.81 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,138 | $537.67 |
| 83690 | <1% | 2,073 | $432.08 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 81 | $424.27 |
| J2704 | Injection, propofol, 10 mg | <1% | 774 | $380.82 |
| 83605 | <1% | 1,493 | $360.93 | |
| 84703 | <1% | 1,396 | $341.06 | |
| 80320 | <1% | 1,993 | $320.22 | |
| 87807 | <1% | 680 | $281.52 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,242 | $280.29 |
| 73630 | <1% | 250 | $275.16 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 123 | $264.18 |
| 87070 | <1% | 692 | $261.06 | |
| 81003 | <1% | 4,596 | $233.77 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,051 | $220.80 |
| 86703 | <1% | 14 | $212.62 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 786 | $204.32 |
| 82948 | <1% | 689 | $203.12 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 287 | $201.55 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | <1% | 853 | $184.48 |
| 94726 | <1% | 12 | $171.60 | |
| 94727 | <1% | 12 | $159.96 | |
| 73130 | <1% | 182 | $153.11 | |
| 73562 | <1% | 133 | $141.45 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 250 | $137.60 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 899 | $131.79 |
| 85379 | <1% | 841 | $129.40 | |
| 84439 | <1% | 28 | $126.00 | |
| 59025 | Fetal non-stress test | <1% | 12 | $120.00 |
| 87186 | <1% | 262 | $118.41 | |
| 80299 | <1% | 197 | $104.83 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 607 | $97.36 |
| 88304 | <1% | 14 | $91.34 | |
| 73610 | <1% | 200 | $82.66 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 629 | $75.20 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 442 | $67.91 |
| 94761 | <1% | 1,262 | $64.35 | |
| 80349 | <1% | 338 | $55.00 | |
| 96376 | <1% | 293 | $52.70 | |
| 84702 | <1% | 70 | $49.72 | |
| 94760 | <1% | 884 | $44.43 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 125 | $39.14 |
| 73110 | <1% | 24 | $37.90 | |
| 73030 | <1% | 42 | $36.18 | |
| 87040 | <1% | 192 | $35.58 | |
| 86618 | <1% | 25 | $34.06 | |
| 87430 | <1% | 458 | $28.28 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 16 | $27.95 |
| 86171 | <1% | 422 | $27.61 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 179 | $26.67 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 255 | $22.30 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 309 | $18.33 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 485 | $12.46 |
| 87077 | <1% | 71 | $8.08 | |
| 85008 | <1% | 550 | $7.92 | |
| 85651 | <1% | 24 | $5.65 | |
| 87081 | <1% | 342 | $5.30 | |
| 80353 | <1% | 14 | $5.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 26 | $2.72 |
| 85007 | 0% | 185 | $0.00 | |
| 83721 | 0% | 140 | $0.00 | |
| 80321 | 0% | 322 | $0.00 | |
| 94799 | 0% | 15 | $0.00 | |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 14 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 13 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 17 | $0.00 |
| 93799 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBAKER, PATRICK (AVP, REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Margaretville Memorial Hospital | Margaretville, NY | $1.10M |
| Healthalliance Hospital Marys Avenue Campus | Kingston, NY | $34K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.